ChemoCentryx Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
50.38 M |
Public Float |
24.94 M |
ChemoCentryx Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.8 |
Market Cap |
$516.05 M |
Shares Outstanding |
58.05 M |
Public Float |
30.54 M |
Address |
850 Maude Avenue Mountain View California 94043 United States |
Employees | - |
Website | http://www.chemocentryx.com |
Updated | 07/08/2019 |
ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. |